In a word, the STING-dependent signaling pathway can be activated in various cells such as T-cells, B cells, macrophages, NK cells, and some other leukocytes, therefore playing a central role in innate and adaptive immune responses that should be applied in cancer immunotherapy (146, 147). The gene discussed is STING1; the disease is cancer.